跳至主要内容
临床试验/NCT04445779
NCT04445779Unknown不适用

Q10 Preloading Before Cardiac Surgery for Kidney Failure Reduction

Clinical Hospital Center, Split1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Difference in serum creatinine after cardiac surgery indicating kidney injury.

研究概览

简要总结

Coenzyme Q10 (CoQ10) is an essential molecule in human body. It acts as an antioxidant, a co-factor for energy conversion in mitochondria and has anti-inflammatory effects capable of improving endothelial function. Our goal is to investigate whether CoQ10 is capable to reduce the incidence of acute kidney injury/failure following cardiac surgery. Cardiac surgery is major risk factor for acute kidney injury/failure (AKI/F).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients scheduled for elective cardiac surgery

排除标准

  • •patients receiving high dose vitamin B supplementation (defined as more that 200% of recommended daily allowances)
  • •patients under warfarin therapy
  • •urgent surgery
  • •end stage kidney disease
  • •therapy with multiple nephrotoxic drugs
  • •chronic kidney disease
  • •obstructive uropathy
  • •previous cardiac surgery procedure
  • •alcohol abuse
  • •malignancy
  • •allergy to any ingredient of Myoqinon capsule
  • •patients receiving Myoqinon and fail to demonstrate a significant increase in blood concentration of Q10
  • •uncontrolled hypertension

研究组 & 干预措施

Placebo

Placebo Comparator

Patients will receive per-orally placebo in three divided doses.

干预措施: Coenzyme Q10 (Dietary Supplement)

CoQ10

Experimental

Patients will receive per-orally 10 mg/kg of body weight of coenzyme Q10 in the form of Myokinon (PharmaNord, Denmark) in three divided doses. They will receive therapy for at least 10 days before the surgical procedure.

干预措施: Coenzyme Q10 (Dietary Supplement)

结局指标

主要结局

Difference in serum creatinine after cardiac surgery indicating kidney injury.

时间窗: 7 days

Increase in serum creatinine as defined by KDIGO stages will be used as indicator of kidney injury.

Difference in urinary low molekular weight alpha 1 microglobulin as an indicator of kidney tubular injury.

时间窗: 3 days

Alpha 1 microglobulin is an indicator of kidney tubular damage, measured in urine.

Daily urine output during the 72 hours postoperatively.

时间窗: 3 days

Urine output less than 0.5 ml/kg/h during 6 hours indicates increased risk of developing AKI.

次要结局

  • Advanced glycation endproducts(7 days)
  • Length of stay in intensive care unit(10 days)

研究者

发起方
Clinical Hospital Center, Split
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hrvoje Vučemilović

Hrvoje Vučemilović, Principal Investigator

Clinical Hospital Center, Split

研究点 (1)

Loading locations...

相似试验

Q10 Preloading Before Cardiac Surgery for Kidney... | 临床试验